Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody.
Bernard Sean RegidorDilawer SiddiqiBethany Marie BeattyMarissa-Skye GoldwaterScott JewSean BujarskiRegina SwiftSusanna KimJames R BerensonPublished in: European journal of haematology (2022)